Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Cancer Treat Rev ; 108: 102408, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-35623220

RESUMO

The general nutritional status of cancer patients could be a central determinant of cancer treatment-related toxicity and an indicator of cancer symptoms such as cancer-related cachexia and weight loss. This narrative scientific review covers the impact of dietary patterns (for example, Mediterranean diet, short-term fasting, ketogenic diet), dietary components (for example, fruits and vegetables, fish oils, turmeric/curcumin, dietary fiber, phytochemicals, vitamin/mineral dietary supplements), and the gut microbiota on symptoms, toxicities, and adverse events associated with cancer treatment. Although several studies have produced controversial or inconclusive results, some promising preclinical studies and initial clinical trials suggest that dietary interventions may alleviate certain cancer treatment-related symptoms and toxicities. Possible mechanisms by which dietary components may influence symptomatic and non-symptomatic toxicities during cancer treatment include through impacting inflammation, oxidative stress, muscle mass, cardiac health and regulating the gut microbiome. Current ongoing studies will continue to shed light on whether specific dietary interventions, with a special emphasis on the gut microbiota, are an effective method to improve cancer treatment outcomes. Future studies should examine the synergistic effects of combining different nutritional interventions and establish diet-related guidelines for cancer treatment.


Assuntos
Microbioma Gastrointestinal , Neoplasias , Dieta , Fibras na Dieta , Humanos , Neoplasias/terapia
2.
Br J Cancer ; 123(10): 1496-1501, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32868897

RESUMO

BACKGROUND: Our objective was to determine the correlation between preclinical toxicity found in animal models (mouse, rat, dog and monkey) and clinical toxicity reported in patients participating in Phase 1 oncology clinical trials. METHODS: We obtained from two major early-Phase clinical trial centres, preclinical toxicities from investigational brochures and clinical toxicities from published Phase 1 trials for 108 drugs, including small molecules, biologics and conjugates. Toxicities were categorised according to Common Terminology Criteria for Adverse Events version 4.0. Human toxicities were also categorised based on their reported clinical grade (severity). Positive predictive values (PPV) and negative predictive values (NPV) were calculated to determine the probability that clinical studies would/would not show a particular toxicity category given that it was seen in preclinical toxicology analysis. Statistical analyses also included kappa statistics, and Matthews (MCC) and Spearman correlation coefficients. RESULTS: Overall, animal toxicity did not show strong correlation with human toxicity, with a median PPV of 0.65 and NPV of 0.50. Similar results were obtained based on kappa statistics and MCC. CONCLUSIONS: There is an urgent need to assess more novel approaches to the type and conduct of preclinical toxicity studies in an effort to provide better predictive value for human investigation.


Assuntos
Antineoplásicos/efeitos adversos , Ensaios Clínicos Fase I como Assunto/estatística & dados numéricos , Avaliação Pré-Clínica de Medicamentos/estatística & dados numéricos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/diagnóstico , Neoplasias/tratamento farmacológico , Animais , Antineoplásicos/administração & dosagem , Ensaios Clínicos Fase I como Assunto/normas , Modelos Animais de Doenças , Cães , Avaliação Pré-Clínica de Medicamentos/normas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/epidemiologia , Haplorrinos , Humanos , Camundongos , Neoplasias/epidemiologia , Neoplasias/patologia , Prognóstico , Ratos
3.
JCO Clin Cancer Inform ; 2: 1-14, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30652565

RESUMO

PURPOSE: We examined patterns, correlates, and the impact of cancer-related Internet use among patients with advanced cancer in a phase I clinical trials clinic for molecularly targeted oncologic agents. METHODS: An anonymous questionnaire on Internet use for cancer-related purposes that incorporated input from phase I clinical trial oncologists and patients was self-administered by patients age ≥ 18 years in a phase I clinic. Multivariable modeling was used. Data were analyzed for the overall sample and by generation, which was defined by year of birth. RESULTS: Of 291 patients (52% women, 82% non-Hispanic white, 50% age ≤ 60 years), 62% were cancer-related Internet users (CIUs). Cancer-related Internet use was associated with an income of ≥ $60,000 (odds ratio, 2.42; P = .004). CIUs used the Internet to learn about their cancer (85%), treatment adverse effects (65%), clinical trials (52%), new alternative treatments (42%), and symptom management (41%). CIUs most frequently used the hospital Web site (70%) to learn about clinical trials, followed by ClinicalTrials.gov (42%) and search engines (41%). The emotional impact of Internet-derived cancer information on CIUs varied-56% felt empowered, 34% anxious, 29% relieved, and 17% confused. Cancer-related Internet information made 51% of patients from the Millennial (born after 1990) and Generation X/Y (born 1965 to 1990) CIU populations anxious compared with < 29% of CIUs from older generations (born 1964 and before). Most CIUs desired more online information about new experimental drugs (91%) and US Food and Drug Administration-approved drugs for cancer (72%). CONCLUSION: As most phase I patients use the Internet for cancer-related purposes, the Internet overall and hospital Web sites should provide more extensive, pertinent, and helpful information on clinical trials and cancer treatment to phase I patients.


Assuntos
Ensaios Clínicos Fase I como Assunto/estatística & dados numéricos , Assistência Integral à Saúde , Informação de Saúde ao Consumidor/estatística & dados numéricos , Internet/estatística & dados numéricos , Informática Médica/estatística & dados numéricos , Neoplasias/psicologia , Redes Sociais Online , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/diagnóstico , Neoplasias/terapia , Inquéritos e Questionários
4.
J Am Diet Assoc ; 111(3): 385-93, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21338737

RESUMO

BACKGROUND AND OBJECTIVE: The purpose of this study was to examine associations among dietary supplement use and dietary/activity patterns in a representative sample of adolescents by sex and race/ethnicity, a research area where extant data is limited. DESIGN/PARTICIPANTS: Cross-sectional, multistage, probability-based sample of 11th graders in Texas during 2004-2005 (n=6,422; 48.8% white/other, 37% Hispanic, and 14.2% African American; 50.6% boys; mean age 16.7 years). SETTING: Classrooms. MAIN VARIABLES ASSESSED: Dietary supplement use, dietary/activity patterns, and anthropometrics. STATISTICAL ANALYSES PERFORMED: Multiple logistic regression models (odds ratios [ORs] and 95% confidence intervals [CIs]). RESULTS: Dietary supplement users reported healthy dietary and physical activity behaviors overall, yet sex- and race/ethnicity-specific differences were seen in associations among specific diet/activity behaviors and supplement use. In whites/others and Hispanics, but not African Americans, supplement use was associated with higher diet quality scores (OR 2.93, 95% CI 1.74 to 4.95 for whites/others; OR 3.93, 95% CI 2.26 to 6.83 for Hispanics), and regular consumption of breakfast (OR 2.27, 95% CI 1.40 to 3.66 for whites/others; OR 1.96, 95% CI 1.11 to 3.46 for Hispanics) and low-fat foods (OR 3.02, 95% CI 1.53 to 5.98 for whites/others; OR 3.59, 95% CI 1.11 to 11.6 for Hispanics). Supplement use was not associated with body mass index or with sedentary behaviors overall, but was associated with less television viewing only in whites/others (OR 0.53, 95% CI 0.33 to 0.84). For physical activity, boys and whites/others showed positive associations between supplement use and all indicators examined, but girls, Hispanics and African Americans showed mixed patterns of associations. Supplement use was associated with higher weight preference only in boys (OR 2.47, 95% CI 1.24 to 4.90), and vegetarian diets only in girls (OR 2.96, 95% CI 1.35 to 6.47). CONCLUSIONS: Dietary and activity patterns associated with dietary supplement use may vary by sex- and racial/ethnic subpopulation, especially amongst African American youth. These findings together with further research on psychosocial and attitudinal characteristics associated with adolescent supplement use can enhance the development of targeted and tailored health communications about supplement use in adolescent subpopulations.


Assuntos
Atitude Frente a Saúde , Suplementos Nutricionais/estatística & dados numéricos , Etnicidade/psicologia , Etnicidade/estatística & dados numéricos , Comportamentos Relacionados com a Saúde/etnologia , Adolescente , Negro ou Afro-Americano/psicologia , Negro ou Afro-Americano/estatística & dados numéricos , Antropometria , Intervalos de Confiança , Feminino , Hispânico ou Latino/psicologia , Hispânico ou Latino/estatística & dados numéricos , Humanos , Modelos Logísticos , Masculino , Razão de Chances , Fatores Sexuais , Texas , População Branca/psicologia , População Branca/estatística & dados numéricos
5.
J Nutr Educ Behav ; 41(2): 95-102, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19304254

RESUMO

OBJECTIVE: To examine diet- and body size-related attitudes and behaviors associated with supplement use in a representative sample of fourth-grade students in Texas. DESIGN: Cross-sectional data from the School Physical Activity and Nutrition study, a probability-based sample of schoolchildren. Children completed a questionnaire that assessed supplement use, food choices, diet-related attitudes, and physical activity; height and weight were measured. SETTING: School classrooms. PARTICIPANTS: Representative sample of fourth-grade students in Texas (n = 5967; mean age = 9.7 years standard error of the mean [SEM] = .03 years, 46% Hispanic, 11% African-American). MAIN OUTCOME MEASURES: Previous day vitamin supplement consumption, diet- and body size-related attitudes, food choices, demographic factors, and physical activity. ANALYSIS: Multivariable logistic regression models, P < .05. RESULTS: The prevalence of supplement use was 29%. Supplement intake was associated with physical activity. Girls who used supplements were more likely to report positive body image and greater interest in trying new food. Relative to nonusers, supplement users were less likely to perceive that they always ate healthful food, although supplement use was associated with more healthful food choices in boys and girls (P < .001). CONCLUSIONS AND IMPLICATIONS: The widespread use of supplements and clustering of supplement use with healthful diet and greater physical activity in fourth graders suggest that supplement use be closely investigated in studies of diet-disease precursor relations and lifestyle factors in children.


Assuntos
Comportamento Infantil/psicologia , Dieta , Comportamento Alimentar , Comportamentos Relacionados com a Saúde , Conhecimentos, Atitudes e Prática em Saúde , Vitaminas/administração & dosagem , Tamanho Corporal , Criança , Estudos Transversais , Comportamento Alimentar/etnologia , Feminino , Comportamentos Relacionados com a Saúde/etnologia , Humanos , Modelos Logísticos , Masculino , Atividade Motora , Estudantes , Inquéritos e Questionários , Texas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA